Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement to 30 September 2010

17 Nov 2010 07:00

RNS Number : 3009W
British Smaller Companies VCT2 Plc
17 November 2010
 



BRITISH SMALLER COMPANIES VCT2 PLC ("the Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2010

 

The Company presents its interim management statement for the quarter ended 30 September 2010. This constitutes the Company's second interim management statement for the financial year ending 31 December 2010, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfm.co.uk.

 

The unaudited net asset value per Ordinary share as at 30 September 2010 was 66.2p (30 June 2010: 70.1p). The 3.9p reduction in the quarter is primarily due to 2.0p per share final dividend paid 30 September 2010 along with a downward movement in the valuation of the unquoted portfolio.

 

The total return at 30 September 2010, calculated by reference to the net asset value per share and the cumulative dividends paid, is 92.2p per share compared to 94.1p at 30 June 2010.

 

The number of Ordinary shares in issue at 30 September 2010 was 17,837,519. There were no shares purchased or issued by the Company during the quarter.

 

Pursuant to the resolution passed at the General Meeting on 18 October 2010 the name of the Company was changed from British Smaller Technology Companies VCT2 plc to British Smaller Companies VCT2 plc with effect from 22 October 2010. A further resolution was passed at this meeting (as set out in the RNS announcement on 20 October 2010) for the Company to make market purchases of its own shares.

 

Net assets at 30 September 2010 comprised the following:

 

£000

% of net assets

Unquoted investments at fair value

5,260

44.5

Quoted investments at bid price

905

7.7

Gilt investments

4,042

34.2

Total financial assets at fair value

10,207

86.4

Cash and cash equivalents

1,329

11.3

Other net current assets (liabilities)

275

2.3

Net assets

11,811

100.0

 

 

The ten largest investments by valuation at 30 September 2010 were as follows:

 

Current cost

£000

Value

£000

% of net assets

Primal Pictures Limited

897

1,184

10.0

Digital Healthcare Limited

3,072

1,156

9.8

Immunobiology Limited

1,032

1,002

8.5

Bluebell Telecom Group

500

500

4.2

Waterfall Services Limited

250

494

4.2

Pressure Technologies plc

300

350

3.0

Patsystems plc

317

311

2.6

Harvey Jones Limited

389

273

2.3

Deep-Secure Ltd

500

250

2.1

RMS Group Holdings Limited

210

140

1.2

Top 10 investments

7,467

5,660

47.9

Other 11 investments

2,521

505

4.3

Gilt investments

3,974

4,042

34.2

Total

13,962

10,207

86.4

 

Quoted investments are carried at bid price at 30 September 2010, discounted for liquidity as appropriate. Unquoted investment are carried at fair value as at 30 September 2010 as determined by the directors.

 

During September 2010 the Company invested £500,000 into the newly formed Bluebell Telecom Group, based in Newcastle-Upon-Tyne, a business seeking to consolidate activities in the telecoms service sector.

 

Shortly after the period end the Company invested £267k as part of a £3m funding syndicate into medical technology business, Sirigen Group Limited.

 

During the three months ended 30 September 2010 the following significant investment disposals took place (all companies are unquoted except where otherwise indicated):

 

Partial Disposals

Name of company:

Sale proceeds

 

£000

Original

cost

 

£000

Carrying value at

31 Dec 2009

 

£000

Primal Pictures Limited

69

22

69

RMS Group Holdings Limited

182

171

138

DxS Limited

165

-

-

416

193

207

 

 

Performance

 

In this period the Company has seen its total return, calculated by reference to the net asset value plus cumulative dividend paid, decrease by 1.9p to 92.2p per share, cumulative dividends representing 26.0p per share.

 

The net asset value currently comprises 45% in cash and gilts and as such the Company is well placed to take advantage of selective investment opportunities as they arise.

 

The discount of the share price to the net asset value per share has reduced to around 15% as a result of the introduction of the share buyback policy in October 2010.

 

Outlook 

 

Whilst significant uncertainty still exists, this period has also seen continuing signs of economic recovery benefiting a number of the portfolio businesses, with good realisation opportunities now available for quality businesses.

 

The number of new investment opportunities has increased, with more management teams seeking to expand and vendors prepared to sell, which your Board believes will translate into increasing investment opportunities over the short and medium term. This Company is well placed to take advantage of these investment opportunities as well as continuing to support its existing investments. To take full advantage of this market opportunity the board is seeking to increase the investment capacity of the Company via a linked offer together with the British Smaller Companies VCT plc over the coming months.

 

17 November 2010

 

For further information please contact:

 

David Hall YFM Private Equity Tel: 0161 832 7603

Jeff Keating Singer Capital Markets Tel: 0203 205 7500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGGBWGUPUGMQ
Date   Source Headline
6th May 20267:00 amRNSDividend Declaration
20th Apr 202610:01 amRNSAdmission to Trading
1st Apr 20269:00 amRNSIssue of Equity
27th Mar 20264:12 pmRNSTransaction in Own Shares
23rd Mar 202610:45 amRNSPublication of a Supplementary Prospectus
19th Mar 20267:00 amRNSAnnual Financial Report
30th Jan 20267:00 amRNSAdmission of Further Securities to Trading
7th Jan 20269:31 amRNSDirector/PDMR Shareholding
7th Jan 20269:30 amRNSIssue of Equity
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
22nd Dec 20259:13 amRNSTransaction in Own Shares
22nd Dec 20259:13 amRNSTransaction in Own Shares
18th Dec 202512:14 pmRNSClose of Offers to new Applications
18th Dec 202512:14 pmRNSClose of Offers to new Applications
28th Nov 202510:00 amRNSInterim Management Statement
20th Nov 20259:00 amRNSOffer Update
31st Oct 202510:01 amRNSPayment of dividend and issue of Equity
10th Oct 20253:41 pmRNSOffer Update
2nd Oct 20259:00 amRNSOffer Update
25th Sep 20259:04 amRNSPublication of a Prospectus
23rd Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSHalf-year Report
22nd Aug 202510:45 amRNSNew combined offer for subscription
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 202510:20 amRNSPayment of Dividend and Issue of Equity
13th Jun 20251:30 pmRNSInterim Management Statement
12th Jun 202510:46 amRNSResult of AGM
13th May 202512:54 pmRNSDividend Declaration
1st Apr 20258:02 amRNSDirector/PDMR Shareholding
1st Apr 20258:00 amRNSIssue of Equity
26th Mar 20255:15 pmRNSTransaction in Own Shares
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
18th Mar 20251:00 pmRNSAnnual Financial Report
30th Jan 20259:05 amRNSDirector/PDMR Shareholding
30th Jan 20259:00 amRNSIssue of Equity
27th Jan 20259:21 amRNSPayment of dividend and issue of shares
8th Jan 20252:14 pmRNSClose of Offer to new Applications
8th Jan 20252:13 pmRNSClose of Offer to new Applications
17th Dec 20242:13 pmRNSNominal Capital Reduction
17th Dec 20247:00 amRNSDividend Declaration
16th Dec 20245:08 pmRNSTransaction in Own Shares
29th Nov 20249:00 amRNS3rd Quarter Results
20th Nov 20241:00 pmRNSOffer Update
20th Nov 20241:00 pmRNSOffer Update
12th Nov 20241:52 pmRNSResult of General Meeting
1st Nov 202411:04 amRNSPayment of Dividend and Allotment of Shares
1st Nov 20247:00 amRNSOffer Update
1st Nov 20247:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.